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Letters to the Editor
A Small Outbreak of
Spontaneous Abortion
in Four Patients From
Two Households
To the Editor:
Two sisters, Patient K (age
36) and Patient S (age 38) lived in
the same household and shared all
foods prepared in their home.
Patient K was pregnant, and her
sister, Patient S, became pregnant
two months later. Patient K suf-
fered a sudden, spontaneous abor-
tion; two months later, Patient S
also suffered a spontaneous abor-
tion.
Two sisters-in-law, Patient L
(age 33) and Patient 2 (age 27),
resided in the same household
and shared all meals. About two
months after Patient Z became
pregnant, Patient L also became
pregnant. Patient Z’s pregnancy
ended in spontaneous abortion,
and two months later, Patient L
also suffered a spontaneous ab r-
tion.
All four patients had positive
indirect hemagglutination (IHA)
tests for toxoplasmosis.
Over a five-year period, 139
pregnant women visiting the
Mother and Child Care Center in
Risafa, Iraq, tested IHA-positive
for toxoplasmosis infection; how-
ever, only four women (two pairs
of women, each pair sharing house-
holds) had spontaneous abortions.
Women with serological evidence
of toxoplasmosis infection prior to
pregnancy do not infect their neo-
nate; the fetus may be at risk only
when primary infection is acquired
during pregnancy.’ Toxoplasmosis
is transmitted to the fetus in utero
during a pregnancy only as a result
of parasitemia.Q
The modes of transmission of
toxoplasmosis in our culture, and
especially in our four patients, have
not been definitively established.
Cooked meat cannot be consid-
ered a vehicle for infection in Iraq.
However, direct contamination by
flies3 and cockroaches4 serving as
the mechanical carriers for the
oecyst from cat feces is possible.
There is a close association
between the prevalence of toxoplas-
mosis in humans and the presence
of toxoplasmosis in domestic
cats.5T6
Toxoplasmosis infection is a
preventable disease, and, even
when primary infection occurs dur-
ing pregnancy, early diagnosis and
treatment can reduce the fre-
quency and severity of disease in
the neonate.7
Abdulsamad A. Abood, MD
Ministry of Higher Education
and Scientific Research
Baghdad, Iraq
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Parenteral Versus
Antimicrobials
To the Editor:
Gynecol.
Oral
I read with great interest the
recent report by Ehrenkranz et l.’
However, I had several questions.
The study was undertaken to pro-
mote a change from parenteral to
oral antimicrobials with equivalent
therapeutic actions. However, inter-
vention also was regarded as suc-
cessful if antimicrobial treatment
was discontinued; this is not con-
sistent with the study question.
The rate of treatments that were
discontinued rather than changed
to an oral regimen should be
reported. No sample size determi-
nations were reported in this clini-
cal trial. Because similar outcomes
of mortality and secondary infec-
tions were observed, the power of
the study should be stated to allow
the reader to assess the probabil-
ity of Type II error.2
Student’s t tests and Fisher’s
exact tests were used to analyze
the data. In Table 2, multiple com-
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parisons were performed, but the
authors do not mention whether
there was use of a method for
adjustment for multiple com-
parisons.3 Interestingly, days of
corticosteroid use were reportedly
longer in the compliant group com-
pared with the noncompliant group.
However, the different standard devi-
ations suggest that the variances of
the two groups may be significantly
different. What method was used
for adjustment of unequal variances,
if it was necessary?
A higher proportion of patients
in the noncompliant group had ther-
apy for resistant pathogens, a
marker for the severity of pneumo-
nia. Therefore, one cannot conclude
that patients in the noncompliant
group were comparable with the
compliant (or control) group. The
small sample size precludes mean-
ingful statistical analysis, revealing
the power to detect a difference of
approximately 33% in this particular
example.4 Furthermore, a new-site
pulmonary infection was observed
in patients of three compliant physi-
cians compared with one in the
control group; two deaths occurred
in patients of the compliant group
compared with none in the non-
compliant group. This suggests that
patients of noncompliant physicians
may have a better outcome than
patients of compliant physicians
who discontinued parenteral ther-
apy when contacted. Although
there were no statistically signifi-
cant differences observed in these
patients, the study power was inad-
equate to evaluate these important
outcomes.
Patients of noncompliant phy-
sicians had a longer length of hos-
pital stay, a higher rate of phlebitis,
and higher laboratory costs than
the control group. Perhaps non-
compliant physicians may differ
inherently from control physicians,
independent of the intervention.
The results from the pilot study
may have given further infor-
mation that differentiated noncom-
pliant physicians from others. The
followup period of one month
ap ears too brief to adequately
detect late manifestations of infec-
ions at other sites, such as osteo-
myelitis and endocarditis.
In conclusion, the study
ddresses an important question
and may be background for a
larger study where the randomiza-
tion process is not influenced by
physician’s compliance. Such a
study has recently been published
by Sanders et a1.5 The small sam-
ple size, the lack of control for
potential confounder@ in the anal-
ysis, and the duration of the follow-
up limit the validity and the
generalizability of the results.
Andreas  E Widmer, MD
University Hospital
Basil, Switzerland
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The author replies.
I thank Dr Widmer for his
interest in our study. I fear, how-
ever, that he has misread the paper
in a number of important aspects.
In answer to his questions,
the study was undertaken solely to
promote discontinuation of paren-
teral therapy (as indicated in the
title). The stated endpoint defining
physician compliance was cessa-
tion of parenteral antimicrobial
treatment within 48 hours of unso-
licited intervention, without regard
to initiation of oral antimicrobials.
All but one compliant physician,
however, did discontinue paren-
teral treatment in favor of oral
treatment.
Issues of sample size and
study power were addressed in
the discussion.
The multiple univariate com-
parisons set forth in Table 2 are for
group comparisons of as many
patient characteristics as can be
identified. This was done to evalu-
ate comparability of study popula-
tions and is essential to assess the
outcome of the randomization proc-
ess. A secondary question was
whether pertinent differences
existed between patients of com-
pliant or noncompliant physicians.
In this context, adjustments for
multiple comparisons are mean-
ingless; they would not increase
the number of differences between
various groups beyond the one
l eady noted, nor would adjust-
ment for unequal variances
change the findings to make for
longer treatment with cortico-
steroids in other patient sets.
I cannot fathom any biological
relation between a physician’s
choice of oral or parenteral antimi-
crobial therapy for patient man-
agement during hospitalization,
and posthospitalization occurence
i  the same patient of a new aspira-
tion pneumonia or new lobar pneu-
monia at a new anatomic site, or
death unrelated to the original pul-
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